{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"markets","count":1,"filters":{"market":"us-pharmacy-benefit-management","matched":true,"marketId":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"},"rows":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management","shortName":"PBMs","geography":"United States","sector":"Health care","dataVintage":"2023","naicsCode":"524292","industryHref":"/industries/524292","crosswalkHref":"/markets/economy?bridgeMarket=us-pharmacy-benefit-management&bridgeNaics=524292#market-industry-crosswalk","latestHhi":null,"concentrationClass":null,"cr4":null,"topFirmShare":null,"hhiAtOrAbove2500":null,"hhiDisclosureGap":true,"dataStatus":"incomplete","confidenceLevel":"high","sourceCount":1,"policySourceCount":4,"policyEventCount":4,"reportCount":2,"briefAction":"Publish firm-level shares, ownership/control links, and market-definition notes before public agencies rely on private estimates.","briefActionLevel":"Evidence build","briefChange":"The current public record does not provide a definition-stable firm-level HHI series.","briefComparisonDelta":null,"briefComparisonDirection":"unavailable","briefComparisonFromYear":null,"briefComparisonMetric":null,"briefComparisonToYear":null,"briefEvidence":"4 records in the evidence custody chain, 0 latest share rows, 4 linked official records, and 2 related briefs support this profile. Status is incomplete with high confidence.","briefEvidenceState":"aggregate_only","briefGuardrail":"This brief summarizes the observatory's published market screen. It does not define a legal antitrust market, establish market power, identify anticompetitive conduct, estimate consumer harm, or convert descriptive concentration into a causal claim.","briefHeadline":"PBMs: aggregate concentration evidence, but not the individual shares required for HHI.","briefHref":"/markets/us-pharmacy-benefit-management#overview","briefQuestion":"Which individual firm shares and geographic boundaries are needed to move from aggregate concentration facts to a complete market screen?","briefSourceIds":"ftc-pbm-interim-2024|ftc-pbm-insulin-complaint-2024|ftc-express-scripts-settlement-2026|ftc-caremark-settlement-2026","briefStructure":"The public record reports only aggregate concentration facts. Individual shares do not close a firm-level distribution, so HHI remains withheld."}]}